Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic comparison of intranasal versus buccal lorazepam in healthy adult volunteers
2008-001575-30Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lorazepam in status epilepticus (SE) (2 arms), sponsored by University of Nottingham. Primary endpoints: Plasma concentration–time profile (intranasal vs buccal), Area under the concentration–time curve (AUC) and 5 more. Started Jul 2008; status: completed.
02
Drugs
lorazepam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on 2008-001575-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001575-30.